259 related articles for article (PubMed ID: 35256434)
1. Global challenges of radiotherapy for the treatment of locally advanced cervical cancer.
Mayadev JS; Ke G; Mahantshetty U; Pereira MD; Tarnawski R; Toita T
Int J Gynecol Cancer; 2022 Mar; 32(3):436-445. PubMed ID: 35256434
[TBL] [Abstract][Full Text] [Related]
2. Scale-up of radiotherapy for cervical cancer in the era of human papillomavirus vaccination in low-income and middle-income countries: a model-based analysis of need and economic impact.
Rodin D; Burger EA; Atun R; Barton M; Gospodarowicz M; Grover S; Hanna TP; Jaffray DA; Knaul FM; Lievens Y; Zubizarreta E; Milosevic M
Lancet Oncol; 2019 Jul; 20(7):915-923. PubMed ID: 31151906
[TBL] [Abstract][Full Text] [Related]
3. Radiation oncology management of stage III and IVA cervical carcinoma.
Franco I; Viswanathan AN
Int J Gynecol Cancer; 2022 Mar; 32(3):231-238. PubMed ID: 35256408
[TBL] [Abstract][Full Text] [Related]
4. American Brachytherapy Society: Brachytherapy treatment recommendations for locally advanced cervix cancer for low-income and middle-income countries.
Suneja G; Brown D; Chang A; Erickson B; Fidarova E; Grover S; Mahantshetty U; Nag S; Narayan K; Bvochora-Nsingo M; Viegas C; Viswanathan AN; Lin MY; Gaffney D
Brachytherapy; 2017; 16(1):85-94. PubMed ID: 27919654
[TBL] [Abstract][Full Text] [Related]
5. Increasing global accessibility to high-level treatments for cervical cancers.
Chargari C; Arbyn M; Leary A; Abu-Rustum NR; Basu P; Bray F; Chopra S; Nout R; Tanderup K; Viswanathan AN; Zacharopoulou C; Soria JC; Deutsch E; Gouy S; Morice P
Gynecol Oncol; 2022 Jan; 164(1):231-241. PubMed ID: 34716024
[TBL] [Abstract][Full Text] [Related]
6. Radical radiotherapy in patients with cervix uteri carcinoma: experience of Ondokuz Mayis University.
Serarslan A; Gursel B; Meydan D; Ozbek Okumus N
BMC Cancer; 2019 Dec; 19(1):1208. PubMed ID: 31830953
[TBL] [Abstract][Full Text] [Related]
7. Integrating HPV vaccination programs with enhanced cervical cancer screening and treatment, a systematic review.
Wirtz C; Mohamed Y; Engel D; Sidibe A; Holloway M; Bloem P; Kumar S; Brotherton J; Reis V; Morgan C
Vaccine; 2022 Mar; 40 Suppl 1():A116-A123. PubMed ID: 34863615
[TBL] [Abstract][Full Text] [Related]
8. Phase II study of concurrent chemoradiotherapy with high-dose-rate intracavitary brachytherapy in patients with locally advanced uterine cervical cancer: efficacy and toxicity of a low cumulative radiation dose schedule.
Toita T; Kitagawa R; Hamano T; Umayahara K; Hirashima Y; Aoki Y; Oguchi M; Mikami M; Takizawa K;
Gynecol Oncol; 2012 Aug; 126(2):211-6. PubMed ID: 22555110
[TBL] [Abstract][Full Text] [Related]
9. Cervical cancer: A global health crisis.
Small W; Bacon MA; Bajaj A; Chuang LT; Fisher BJ; Harkenrider MM; Jhingran A; Kitchener HC; Mileshkin LR; Viswanathan AN; Gaffney DK
Cancer; 2017 Jul; 123(13):2404-2412. PubMed ID: 28464289
[TBL] [Abstract][Full Text] [Related]
10. Advances in Radiation Oncology for the Treatment of Cervical Cancer.
Faye MD; Alfieri J
Curr Oncol; 2022 Feb; 29(2):928-944. PubMed ID: 35200578
[TBL] [Abstract][Full Text] [Related]
11. Treatment of cervical cancer: overcoming challenges in access to brachytherapy.
Lichter K; Anakwenze Akinfenwa C; MacDuffie E; Bhatia R; Small C; Croke J; Small W; Chino J; Petereit D; Grover S
Expert Rev Anticancer Ther; 2022 Apr; 22(4):353-359. PubMed ID: 35227148
[TBL] [Abstract][Full Text] [Related]
12. CALLA: Efficacy and safety of concurrent and adjuvant durvalumab with chemoradiotherapy versus chemoradiotherapy alone in women with locally advanced cervical cancer: a phase III, randomized, double-blind, multicenter study.
Mayadev J; Nunes AT; Li M; Marcovitz M; Lanasa MC; Monk BJ
Int J Gynecol Cancer; 2020 Jul; 30(7):1065-1070. PubMed ID: 32447296
[TBL] [Abstract][Full Text] [Related]
13. Impact of Treatment Time on Chemoradiotherapy in Locally Advanced Cervical Carcinoma.
Pathy S; Kumar L; Pandey RM; Upadhyay A; Roy S; Dadhwal V; Madan R; Chander S
Asian Pac J Cancer Prev; 2015; 16(12):5075-9. PubMed ID: 26163644
[TBL] [Abstract][Full Text] [Related]
14. Cervical cancer.
Cohen PA; Jhingran A; Oaknin A; Denny L
Lancet; 2019 Jan; 393(10167):169-182. PubMed ID: 30638582
[TBL] [Abstract][Full Text] [Related]
15. Addressing the burden of cervical cancer through IAEA global brachytherapy initiatives.
Abdel-Wahab M; Grover S; Zubizarreta EH; Polo Rubio JA
Brachytherapy; 2020; 19(6):850-856. PubMed ID: 32928684
[TBL] [Abstract][Full Text] [Related]
16. Does the evidence support the use of concurrent chemoradiotherapy as a standard in the management of locally advanced cancer of the cervix, especially in developing countries?
Datta NR; Agrawal S
Clin Oncol (R Coll Radiol); 2006 May; 18(4):306-12. PubMed ID: 16703748
[TBL] [Abstract][Full Text] [Related]
17. Cervical cancer treatment update: A Society of Gynecologic Oncology clinical practice statement.
Girda E; Randall LM; Chino F; Monk BJ; Farley JH; O'Cearbhaill RE
Gynecol Oncol; 2023 Dec; 179():115-122. PubMed ID: 37980766
[TBL] [Abstract][Full Text] [Related]
18. [Concurrent chemoradiotherapy versus radiotherapy in advanced cervical carcinoma].
Zeng SY; Li LY; Shu KY; Pan M; Li HP; Luo B
Ai Zheng; 2008 Sep; 27(9):942-6. PubMed ID: 18799032
[TBL] [Abstract][Full Text] [Related]
19. Comparison of treatment outcomes between squamous cell carcinoma and adenocarcinoma of cervix after definitive radiotherapy or concurrent chemoradiotherapy.
Hu K; Wang W; Liu X; Meng Q; Zhang F
Radiat Oncol; 2018 Dec; 13(1):249. PubMed ID: 30558636
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
